Sumatriptan and Gallbladder oedema - a phase IV clinical study of FDA data

Summary:

Gallbladder oedema is reported only by a few people who take Sumatriptan.

The phase IV clinical study analyzes which people take Sumatriptan and have Gallbladder oedema. It is created by eHealthMe based on reports of 12,010 people who have side effects while taking Sumatriptan from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

12,010 people reported to have side effects when taking Sumatriptan.
Among them, 2 people (0.02%) have Gallbladder oedema.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 12,929 Sumatriptan users for its effectiveness, alternative drugs and more.

What is Gallbladder oedema?

Gallbladder oedema (swelling of gallbladder) is found to be associated with 514 drugs and 311 conditions by eHealthMe.

Number of Sumatriptan and Gallbladder oedema reports submitted per year:

Could Sumatriptan cause Gallbladder oedema?

Gender of people who have Gallbladder oedema when taking Sumatriptan *:

female: 100 %
male: 0.0 %

Age of people who have Gallbladder oedema when taking Sumatriptan *:

Common drugs people take besides Sumatriptan *:

Common side effects people have besides Gallbladder oedema *:

Wound Infection Staphylococcal: 1 person, 50.00%
Thrombocytopenia (decrease of platelets in blood): 1 person, 50.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 50.00%
Biliary Tract Infection: 1 person, 50.00%
Blindness: 1 person, 50.00%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 1 person, 50.00%
Gallstones (stone formation by bile component): 1 person, 50.00%
Infectious Peritonitis (inflammation of the peritoneum, typically caused by bacterial infection): 1 person, 50.00%
Inflammation: 1 person, 50.00%
Malnutrition (condition that results from eating a diet in which certain nutrients are lacking): 1 person, 50.00%

Common conditions people have *:

Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 50.00%
Nausea (feeling of having an urge to vomit): 1 person, 50.00%
Hepatitis C: 1 person, 50.00%
Abdominal Pain: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and have Gallbladder oedema?

Check whether Gallbladder oedema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gallbladder oedema and when was it recovered:

Gallbladder oedema in Sumatriptan

Expand to all the drugs that have ingredients of sumatriptan succinate:

Gallbladder oedema and drugs with ingredients of sumatriptan succinate

Alternative drugs to, pros and cons of Sumatriptan:

Sumatriptan (12,929 reports)

Common Sumatriptan side effects:

Drug ineffective: 1,817 reports
Migraine (headache): 1,016 reports
Headache (pain in head): 947 reports
Fatigue (feeling of tiredness): 730 reports
Pain: 666 reports
Stress and anxiety: 599 reports
Dizziness: 588 reports

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gallbladder oedema treatments and more:

Gallbladder oedema (375 reports)

COVID vaccines that are related to Gallbladder oedema:

All the drugs that are associated with Gallbladder oedema:

Gallbladder oedema (514 drugs)

All the conditions that are associated with Gallbladder oedema:

Gallbladder oedema (311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan) and Sumatriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.